Melbourne researchers have uncovered key steps involved in programmed cell death, offering new targets for the treatment of diseases including lupus, cancers and neurodegenerative diseases.
13 hours ago
5 / 5 (1) | 0
(Medical Xpress)—Nanoparticles designed to adhere to and light up cancer cells have reached a major milestone in their bench-to-bedside journey. A first clinical trial of these ultrasmall, multifunctional ...
14 hours ago
5 / 5 (8) | 0